Cargando…
Ivabradine, the pure heart rate-lowering drug, shown to reduce morbidity and mortality in heart failure
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782840/ |
Ejemplares similares
-
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
por: Griffiths, A, et al.
Publicado: (2014) -
Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation
por: Tohme, Joanna, et al.
Publicado: (2023) -
Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020) -
Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017) -
Clinical and laboratory characteristics of short-term mortality in Egyptian patients with acute heart failure
por: Abdellah, Ahmad Tageldien, et al.
Publicado: (2017)